Evidence map›Paper›PMID 34469554›Full record

ArticleThe Journal of infectious diseases2021

Impact of Vaccination on Haemophilus influenzae Type b Carriage in Healthy Children Less Than 5 Years of Age in an Urban Population in Nepal.

Sonu Shrestha, Lisa K Stockdale, Madhav C Gautam, Meeru Gurung, Shuo Feng, Pratistha Maskey, Simon Kerridge, Sarah Kelly, Merryn Voysey, Bhishma Pokhrel and 9 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Increase in invasive disease caused byEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 3 countries.

Sonu ShresthaOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Lisa K StockdaleOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.ORCID 0000-0002-2576-8783
Madhav C GautamPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Meeru GurungPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Shuo FengOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Pratistha MaskeyPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Simon KerridgeOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Sarah KellyOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Merryn VoyseyOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.ORCID 0000-0001-6324-6559
Bhishma PokhrelPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Piyush RajbhandariMicrobiology Unit, Department of Pathology and Laboratory Medicine, Patan Academy of Health Sciences, Kathmandu, Nepal.
Stephen ThorsonPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Bibek KhadkaPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Ganesh ShahPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Karin S SchererOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Dominic KellyOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
David R MurdochDepartment of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.
Shrijana ShresthaPediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal.
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford and the National Institute for Health Research Oxford Biomedical Research Centre, Oxford, United Kingdom.
Patan Academy of Health Sciences · NPNational Institute for Health Research · GBUniversity of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundReduction in detection of asymptomatic carriage of Haemophilus influenzae type b (Hib) can be used to assess vaccine impact. In Nepal, routine vaccination against Hib in children at 6, 10, and 14 weeks of age was introduced in 2009. Before vaccine introduction, Hib carriage was estimated at 5.0% among children aged <13 years in Nepal, with higher rates among children under 5. Large-scale evaluation of Hib carriage in children has not been investigated since the introduction of the pentavalent diphtheria-tetanus-pertussis/Hib/hepatitis B (DTP-Hib-HepB) vaccine in Nepal.

methodsA total of 666 oropharyngeal swabs were collected between August and December 2018 from healthy children between 6 months and 5 years of age attending the vaccination clinic at Patan Hospital, Kathmandu, Nepal. Of these 666 swabs, 528 (79.3%) were tested for Hib by culture. Demographic and vaccination data were collected.

resultsAmong 528 swabs tested for Hib, 100% came from fully vaccinated children. No swabs were positive for Hib (95% confidence interval, .0-.7). The absence of Hib in 2018 suggests vaccine-induced protection against Hib carriage 9 years after vaccine introduction.

conclusionsFollowing 3 doses of pentavalent DTP-Hib-HepB vaccine, Hib carriage in children under the age of 5 years in Nepal is no longer common. Ongoing high coverage with Hib vaccine in early childhood is expected to maintain protection against Hib disease in Nepal.

Indexed as

Haemophilus VaccinesVaccinationAntigens, BacterialChildChild, PreschoolDiphtheria-Tetanus-Pertussis VaccineFemaleHaemophilus InfectionsHaemophilus influenzae type bHumansInfantMaleNepalOropharynxUrban PopulationAntigens, BacterialDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinescarriagechildrencolonizationHaemophilus influenzaHibNepalvaccination

Identifiers

PMID34469554
PMCPMC8409530
OpenAlexW3196795575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.